Skip to main content
icon for Which countries will have an Ebola case in 2026?

Which countries will have an Ebola case in 2026?

icon for Which countries will have an Ebola case in 2026?

Which countries will have an Ebola case in 2026?

$34,880 Vol.

30 dez 2026
Polymarket

$34,880 Vol.

Polymarket

South Sudan

$2,171 Vol.

62%

Rwanda

$2,128 Vol.

27%

Burundi

$200 Vol.

29%

United States

$10,215 Vol.

24%

Canada

$1,360 Vol.

24%

Kenya

$235 Vol.

43%

India

$732 Vol.

14%

Republic of the Congo

$12,170 Vol.

26%

Nigeria

$25 Vol.

16%

Ethiopia

$107 Vol.

51%

Somalia

$71 Vol.

33%

China

$3,512 Vol.

12%

This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred. The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.The explosive 2026 Bundibugyo virus outbreak in the Democratic Republic of the Congo, now the country's deadliest with over 5,500 confirmed cases and 2,600 deaths since its May declaration, anchors trader sentiment on the Polymarket. Insecurity, population displacement, and high mobility across porous borders have accelerated transmission to six provinces, outpacing prior epidemics and prompting a WHO public health emergency. Uganda contained its 20 imported cases swiftly, declaring the outbreak over, while isolated detections in France and Germany resolved without further spread. This dynamic elevates implied probabilities for neighbors like South Sudan amid surveillance gaps, while distant markets for the United States or Canada reflect low global risk given contact-based transmission and containment measures. Vaccine shipments and expanded labs offer momentum, yet persistent challenges in early detection keep outcomes fluid through year-end.

This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.

The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Volume
$34,880
Data de Término
31 dez 2026
Mercado Aberto
May 22, 2026, 12:35 PM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred. The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred. The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.The explosive 2026 Bundibugyo virus outbreak in the Democratic Republic of the Congo, now the country's deadliest with over 5,500 confirmed cases and 2,600 deaths since its May declaration, anchors trader sentiment on the Polymarket. Insecurity, population displacement, and high mobility across porous borders have accelerated transmission to six provinces, outpacing prior epidemics and prompting a WHO public health emergency. Uganda contained its 20 imported cases swiftly, declaring the outbreak over, while isolated detections in France and Germany resolved without further spread. This dynamic elevates implied probabilities for neighbors like South Sudan amid surveillance gaps, while distant markets for the United States or Canada reflect low global risk given contact-based transmission and containment measures. Vaccine shipments and expanded labs offer momentum, yet persistent challenges in early detection keep outcomes fluid through year-end.

This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred.

The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.
Volume
$34,880
Data de Término
31 dez 2026
Mercado Aberto
May 22, 2026, 12:35 PM ET

Resolver

0x65070BE91...
This market will resolve to "Yes" if there is a confirmed case of Ebola in the territory of the specified country reported between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". Any active laboratory-confirmed, or otherwise officially confirmed, Ebola infection identified within the territory of the specified country will qualify, regardless of where exposure, symptom onset, or testing occurred. The primary resolution sources for this market will be official information from the relevant national and international health authorities; however, an overwhelming consensus of credible reporting will also suffice.

Relacionado

icon for Ebola pandemic in 2026?

Ebola pandemic in 2026?

4%
icon for Ebola: novo país confirmado antes de 1º de outubro?

Ebola: novo país confirmado antes de 1º de outubro?

57%
Sim
icon for Nova pandemia em 2026?

Nova pandemia em 2026?

6%
Sim

Cuidado com os links externos.

Frequently Asked Questions

"Which countries will have an Ebola case in 2026?" is a prediction market on Polymarket with 13 possible outcomes where traders buy and sell shares based on what they believe will happen. The current leading outcome is "Uganda" at 100%, followed by "South Sudan" at 62%. Prices reflect real-time crowd-sourced probabilities. For example, a share priced at 100¢ implies that the market collectively assigns a 100% chance to that outcome. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

As of today, "Which countries will have an Ebola case in 2026?" has generated $34.9K in total trading volume since the market launched on May 22, 2026. This level of trading activity reflects strong engagement from the Polymarket community and helps ensure that the current odds are informed by a deep pool of market participants. You can track live price movements and trade on any outcome directly on this page.

To trade on "Which countries will have an Ebola case in 2026?," browse the 13 available outcomes listed on this page. Each outcome displays a current price representing the market's implied probability. To take a position, select the outcome you believe is most likely, choose "Yes" to trade in favor of it or "No" to trade against it, enter your amount, and click "Trade." If your chosen outcome is correct when the market resolves, your "Yes" shares pay out $1 each. If it's incorrect, they pay out $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

The current frontrunner for "Which countries will have an Ebola case in 2026?" is "Uganda" at 100%, meaning the market assigns a 100% chance to that outcome. The next closest outcome is "South Sudan" at 62%. These odds update in real-time as traders buy and sell shares, so they reflect the latest collective view of what's most likely to happen. Check back frequently or bookmark this page to follow how the odds shift as new information emerges.

The resolution rules for "Which countries will have an Ebola case in 2026?" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.